CAS 2093387-36-9

3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione

CAS: 2093387-36-9

Formel: C₁₃H₁₁BrN₂O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 323.1420

Ref: IN-DA01JLV3

Lenalidomide-Br

CAS: 2093387-36-9

Lenalidomide-Br

Reinheit: ≥98%

Molekulargewicht: 323.14g/mol

Ref: 54-BUP16792

3-(4-Bromo-1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione

CAS: 2093387-36-9

3-(4-Bromo-1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione

Reinheit: 98%

Molekulargewicht: 323.14g/mol

Ref: 54-OR1010660

3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione

CAS: 2093387-36-9

Formel: C₁₃H₁₁BrN₂O₃

Reinheit: >95.0%(T)(HPLC)

Farbe und Form: White to Dark green to Dark purple powder to crystal

Molekulargewicht: 323.15

Ref: 3B-B6546

Lenalidomide-Br

CAS: 2093387-36-9

Lenalidomide-Br (Compound 41) is a derivative of Lenalidomide, which serves as a ligand for cereblon (CRBN) - an E3 ubiquitin ligase involved in protein

Formel: C₁₃H₁₁BrN₂O₃

Reinheit: 98.37%

Farbe und Form: Solid

Molekulargewicht: 323.14

Ref: TM-T18064

3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione

CAS: 2093387-36-9

Lenalidomide is a small molecule that binds to the CD38 receptor on the surface of cells. This binding leads to a cascade of cellular events that result in inhibition of tumor growth, increased apoptosis and decreased proliferation. The linker is used to attach the ligand to a degradable polymer that can be placed inside cells. Lenalidomide-Br has shown anticancer activity in clinical trials and may be useful as an adjuvant therapy for patients with leukemia.

Formel: C₁₃H₁₁BrN₂O₃

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 323.14 g/mol

Ref: 3D-TID38736

3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione

CAS: 2093387-36-9

Formel: C₁₃H₁₁BrN₂O₃

Reinheit: 97%

Molekulargewicht: 323.146

Ref: 10-F546905